Effect of long-term aspartame (artificial sweetener) on anxiety, locomotor activity and emotionality behavior in Wistar Albino rats

Biomedicine and Preventive Nutrition

Volumn 4, Issue 1, 2014, Pages 39-43

  Ashok, Iyaswamy ^a   Sheeladevi, Rathinasamy ^a   Wankhar, Dapkupar ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Anxiety; Emotionality behavior; Locomotor activity; Long term aspartame; Rat folate deficient model

Indexed keywords

EID: 84894099624     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2013.04.002     Document Type: Article

References (52)

1. Moser R.H. Aspartame and memory loss. JAMA 1994, 272:1543.
2. Newsome R.L. Sweeteners: nutritive and non-nutritive. The Scientific Status Summaries of the Institute of Food Technologies Expert Panel on Food Safety and Nutrition 1986, Institutive of Food Technologies, Chicago.
3. Boehm M.F., Bada J.L. Racemization of aspartic acid and phenylalanine in the sweetener aspartame at 100°C. Proc Natl Acad Sci U S A 1984, 81:5263-5266.
4. Mullenix P.J., Tassinari M.S., Schunior A., Kernan W.J. No change in spontaneous behavior of rats after acute oral doses of aspartame, phenylalanine, and tyrosine. Fundam Appl Toxicol 1991, 16(3):495-505.
5. Christian B., McConnaughcy K., et al. Chronic aspartame in rats affects memory, brain cholinergic receptors, and brain chemistry. Pharm Biochem Behav 2004, 78:121-127.
6. Potts W.J., Bloss J.L., Nutting E.F. Biological properties of aspartame: I evaluation of central nervous system effects. J Environ Pathol Toxicol 1980, 3(5-6):341-353.
7. Kruse J.A. Methanol poisoning. Intensive Care Med 1992, 18:391-397.
8. Lee E.W., Garner C.D., Terzo T.S. Animal model for the study of methanol toxicity: comparison of folate-reduced rat responses with published monkey data. J Toxicol Environ Health 1994, 41:71-82.
9. Eells J.T., Henry M.M., Lewandowski M.F., Seme M.T., Murray T.G. Development and characterization of a rodent model of methanol-induced retinal and optic nerve toxicity. Neurotoxicology 2000, 21:321-330.
10. Roberts H.J. Reactions attributed to aspartame-containing products: 551 cases. J Appl Nutr 1987, 40:85-94.
11. Lipton R.B., Newman L.C., Cohen J.S., Solomon S. Aspartame as a dietary trigger of headache. Headache 1989, 29:90-92.
12. Maher T.J. Neurotoxicology of food additives. Neurotoxicol 1986, 7:183-196.
13. Pinto J.M.B., Maher T.J. Administration of aspartame potentiates pentylenetetrazole- and fluorothyl-induced seizures in mice. Neuropharmacol 1988, 27:51-55.
14. Hall C.S. Emotional behavior in the rat I. Defecation and urination as measures of individual differences in emotionality. J Comp Psychol 1934, 18:385-403.
15. Hall C.S. Emotional behavior in the rat III. The relationship between emotionality and ambulatory activity. J Comp Psychol 1936, 22:345-352.
16. DeFries J.C., Wilson J.R., McClearn G.E. Open-field behavior in mice: selection response and situational generality. Behav Genet 1970, 1:195-211.
17. DeFries J.C., Hegmann J.P., Halcomb R.A. Response to 20 generations of selection for open-field activity in mice. Behav Biol 1974, 11:481-495.
18. DeFries J.C., Gervais M.C., Thomas E.A. Response to 30 generations of selection for open-field activity in laboratory mice. Behav Genet 1978, 8:3-13.
19. Weiss E., Greenberg G. Open-field procedures. Comparative psychology: a handbook 1998, 257-263. Garland, New York. G. Greenberg, M.M. Haraway (Eds.).
20. Liebsch G., Montkowski A., Holsboer F., Landgraf R. Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour. Behav Brain Res 1998, 94:301-310.
21. Blizard D.A. The Maudsley reactive and nonreactive strains: a North-American perspective. Behav Genet 1981, 11:469-489.
22. Asano Y. Characteristics of open field behaviour of Wistar and Sprague-Dawley rats. Exp Anim 1986, 35:505-508.
23. Dawson G.R., Tricklebank M.D. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 1995, 16:33-36.
24. Gentsch C., Lichtsteiner M., Feer H. Locomotor activity, defecation score and corticosterone levels during an open field exposure: a comparison among individually and group-housed rats, and genetically selected rat lines. Physiol Behav 1981, 127:183-186.
25. Courvoisier H., Moisan M.P., Sarrieau A., Hendley E.D., Mormede P. Behavioral and neuro-endocrine reactivity to stress in the WKHA/WKY inbred rat strains: a multifactorial and genetic analysis. Brain Res 1996, 743:77-85.
26. Belzung C., Dubreuil D. Naloxone potentiates the anxiolytic but not the amnestic action of chlordiazepoxide in C57BL/6 mice. Behav Pharmacol 1998, 9:691-698.
27. Rodgers R.J., Johnson N.J. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 1995, 52:297-303.
28. Stegnik L.D., Brummel M.C., et al. Blood Methanol Concentrations in Normal Adult Subjects Administered Abuse dose of Aspartame. J Toxicol Environ Health 1981, 7:281-290.
29. Woodrow C., Monte P.D. Aspartame: Methanol and the Public Health. J Appl Nutr 1984, 36(1):42-53.
30. Humphries P., Pretorius E., Naude H. Direct and indirect cellular effects of aspartame on the brain. Eur J Clin Nutr 2008, 62:451-462.
31. Leon A.S., Hunninghake D.B., Bell C., Rassin D.K., Tephly T.R. Safety of long-term large doses of aspartame. Arch Intern Med 1989, 149(10):2318-2324.
32. Labra-Ruiz N.A., Calderon-Guzman D., Vences-Mejia A., Hernandez-Martinez N., Gardenaarduno J., Dorado-Gonzalez V. Effect of aspartame on the biogenic amines in rat brain. Epidemiology 2007, 18(5):S90-S91.
33. Gonzalez-Quevedo A., Obregon F., Urbina M., Rousso T., Lima L. Effects of chronic methanol administration on amino acid and monoamines in retina, optic nerve, and brain of the rat. Toxicol Appl Pharmacol 2002, 185:77-84.
34. Tabor H., Wyngarden A method for determination of formiminoglutamic acid in urine. J Clin Invest 1962, 37:824-828.
35. Saillenfait A.N., Vannier Methodological proposal in behavioural teratogenecity testing. Neuron 1988, 1(4):279-287.
36. Pellow S., Chopin P., File S.E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Neurosci 1985, 14:149-167.
37. Sanberg P.R., Newman M.B., Manresa J.J., Potts S.E., Alvarez F., Cahill D.W., et al. Mecamylamine effects on haloperidol-induced catalepsy and defecation. Int J Neurosci 2001, 109:81-90.
38. Luo D.D., An S.C., Zhang X. Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress. Brain Res Bull 2008, 77:8-12.
39. Wang D., An S.C., Zhang X. Prevention of chronic stress-induced depression-like behavior by inducible nitric oxide inhibitor. Neurosci Lett 2008, 433:59-66.
40. D'Aquila P.S., Peana A.T., Carboni V., Serra G. Exploratory behaviour and grooming after repeated restraint and chronic mild stress: effect of desipramine. Eur J Pharmacol 2000, 399:43-47.
41. Koob G.F. Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 1999, 46:1167-1180.
42. Katz R.J., Roth K.A., Carroll B.J. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev 1981, 5:247-251.
43. Gharbawie O.A., Whishaw P.A., Whishaw I.Q. The topography of three-dimensional exploration: a new quantification of vertical and horizontal exploration, postural support, and exploratory bouts in the cylinder test. Behav Brain Res 2004, 151:125-135.
44. Broadhurst P.L. The Maudsley reactive and non-reactive strains of rats: a survey. Behav Genet 1975, 5:299-319.
45. Gray J.A. Emotionality in male and female rodents: a reply to Archer. Br J Psychol 1979, 70:435-440.
46. Ashok I., Sheeladevi R Effect of chronic exposure to aspartame on oxidative stress in brain discrete regions of albino rats. J Biosci 2012, 37(4):679-688.
47. Carvalho L., Albrechet-Souza S., Masson M.L., Brand A.O. Changes in the biogenic amine content of the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens of rats submitted to single and repeated sessions of the elevated plus-maze test. Braz J Med Biol Res 2005, 38:1857-1866.
48. Fanselow M.S. Neural organization of the defensive behavior system responsible for fear. Psychonom Bull Rev 1994, 1:429-438.
49. Gray J.A., McNaughton N. Fundamentals of the septohippocampal system. Neuropsychology of anxiety 2000, Oxford University Press, Oxford, UK. J.A. Gray, N. McNaughton (Eds.).
50. Mongeau R., Blier P., de Montigny C. The serotoninergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Rev 1997, 23:145-195.
51. LaBuda C.J., Hale R.L. Anxiety in mice following acute aspartame and ethanol exposure. Alcohol 2000, 20:69-74.
52. Coulombe R.A., Sharma R.P. Neuro biochemical alterations induced by the artificial sweetener aspartame (NutraSweet). Toxicol Appl Pharmacol 1986, 83:79-85.